Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Grass/Rye Pollen Allergoid With MPL in Patients Sensitized to Grass and Rye Pollen

NCT00133159 is registered in ClinicalTrials.gov with Allergy Therapeutics as lead sponsor.

NCT NCT00133159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00133159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Grass/Rye Pollen Allergoid With MPL in Patients Sensitized to Grass and Rye Pollen
Lead sponsor
Allergy Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
September 12, 2005
Completion date
November 8, 2005
Enrollment
68
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type i hypersensitivity